~Raynaud’s syndrome causes white or blue fingertips in the cold or during stressful situations.
~Raynaud’s is caused by vasoconstriction that decreases blood flow to the extremities.
~ Genetics plays a role in who gets Raynauds syndrome.
~ Understanding your genes can help you choose natural solution right for you.
Members will see their genotype report below, plus additional solutions in the Lifehacks section. Consider joining today.
Raynaud’s Syndrome (or Phenomenon) is an episodic vasospastic disorder causing decreased blood flow and numbness in the fingers and other extremities.
As the blood vessels constrict, it reduces the blood flow to the fingers or other extremities. Cold or stress (physical or mental) can trigger the blood vessel constriction..
Women are more likely than men to have Raynaud’s syndrome. Some researchers reports of almost 1 in 5 women having Raynaud’s.[ref]
Often Raynaud’s occurs along with other underlying conditions, such as autoimmune diseases or connective tissue disorders. Sometimes Raynaud’s Phenomenon can be ‘primary’ and occur alone.
Many people with Raynaud’s also have migraines, which may link to vasoconstriction.
Symptoms of Raynaud’s
The drastic color changes in the extremities are a tell-tale sign of this syndrome. It is the first symptom that most people notice with Raynaud’s. The tips of the fingers turn very white from the decreased blood flow and then appear blue or cyanotic with cold or stress. These changes are followed by the fingers turning red when warmed up and blood flow returns (or no longer stressed).
Doctors can use cold provocation or placing the hands in cold, to cause the vessels to constrict. Infrared thermography can then determine the extent of the changes in blood flow to the extremities.[ref]
While it is easy to think of Raynaud’s as just ‘fingers turning white in the cold’, restricting blood to the extremities can be very painful and can cause irreversible tissue damage in severe cases.[ref]
Causes of Raynaud’s syndrome
Spasms or constrictions in the blood vessels seem to be the cause of Raynaud’s. It is an exaggeration of the typical response of blood vessels to either cold or emotional stress.[ref]
Some researchers theorize that the cause of the spasms in the blood vessels comes from the impaired functioning of the adrenergic receptors in the vascular muscle cells. Three types of adrenergic receptors are responsible for constricting or relaxing the muscles surrounding the blood vessels. One adrenergic receptor subtype activates with cold and norepinephrine (noradrenaline), which also releases stressful situations.[ref]
The blood vessel spasms can be ‘primary’ or ‘secondary’.
Primary Raynaud’s, often referred to as idiopathic, meaning the cause is unknown. This unknown reason causes the overreaction of the blood vessel constriction to the extremities.
Secondary Raynaud’s is associated with autoimmune diseases, connective tissue disorders, or medication interactions.
Autoimmune diseases that are more likely to cause Raynaud’s include:[ref]
- systemic sclerosis
- systemic lupus erythematosus
- Sjögren’s syndrome
Raynaud’s can be one of the first symptoms of certain autoimmune diseases, giving doctors and patient’s a ‘heads up’ to look for diseases early.[ref]
Talk with your doctor if you have Raynaud’s. Getting a test for specific autoantibodies in autoimmune diseases may help you get quicker treatment.
For example, antinuclear antibodies often help diagnose these autoimmune diseases (lupus, Sjögren’s, and systemic sclerosis). Other antibodies can indicate antisynthetase syndrome. “The antisynthetase syndrome (ASSD) is an autoimmune disorder characterized by myositis, arthritis, mechanic’s hands, fever, Raynaud phenomenon, and interstitial lung disease (ILD).”[ref]
Raynaud’s phenomenon is also associated with connective tissue disorders, such as Ehlers Danlos Syndromes.[ref][ref]
Related Article: Genetics and Ehlers Danlos Syndrome
Triggers of Raynaud’s Syndrome
The reduction of blood flow in the extremities seen in Raynaud’s phenomenon can be triggered by:[ref]
- chemical exposure
- repetitive actions
- Vibrations (using tools such as a jackhammer)
Cold: A natural reaction to cold is for blood vessels in the fingers and toes to constrict. But in Raynaud’s, the constriction doesn’t ease and is more exaggerated than normal.
Medications: Several classes of medications can cause Raynaud’s phenomenon. The highest risk occurs with cisplatin and bleomycin, but β-adrenoceptor blockers (a.k.a beta-blockers) are a very common medication that may cause Raynaud’s in some people. For others, migraine medications, such as triptans, have links to Raynaud’s.[ref]
Vibration: Vibration white finger is often the term applied to Raynaud’s syndrome caused by mechanical vibration. People who work with vibrating machinery are at about a 4-fold increased risk of Raynaud’s.[ref]
Chemical exposure: In addition to medications, chemicals such as vinyl chloride can also cause Raynaud’s.[ref] Arsenic exposure is also associated with Raynaud’s.[ref]
Why is Raynaud’s found more commonly in women?
Researchers think that Raynaud’s may be more common in premenopausal women due to estrogen’s impact on vasoconstriction through the α2C-AR (alpha(2C)-adrenoceptors) receptors located in blood vessels. Estrogen also plays a role in regulating body temperature. Research shows that post-menopausal women on estrogen-only hormone replacement therapy also have a higher incidence of Raynaud’s.[ref][ref]
Is Raynaud’s syndrome genetic?
Research shows that Raynaud’s runs in families and seems to be about 30% hereditary.[ref][ref] This means that genetic variants increase the susceptibility to Raynauds, but there isn’t a single gene mutation or variant that causes it by itself. Like most conditions, Raynaud’s is likely due to genetic susceptibility combined with a triggering factor.
The genetics section below highlights some genetic variants associated with an increased relative risk of Raynaud’s.
Raynaud’s syndrome and COVID-19 vaccination
Case reports of Raynaud’s after SARS-CoV-2 vaccination include a 31-year-old woman with a new onset of Raynaud’s after the vaccine.[ref] The VAERS database also lists (as of Sept. 2021) 179 cases of Raynaud’s coinciding with the SARS-CoV-2 vaccines. To see this reference, go to medalerts.org and search for Raynaud’s symptoms and COVID-19 vaccines.
Keep in mind that it could be entirely coincidental for Raynaud’s to occur post-vaccine. The 179 reports in VAERS are not all that many in comparison to other post-vaccination symptoms.
Raynaud’s Syndrome Genotype Report
Not a member? Join here. Membership lets you see your data right in each article and also gives you access to the member’s only information in the Lifehacks sections.
NOS1 gene: encodes nitric oxide synthase, which contracts blood vessels and is responsive to cold
Check your genetic data for rs527590 (AncestryDNA):
- T/T: increased susceptibility to Raynaud’s syndrome[ref]
- C/T: increased susceptibility to Raynaud’s syndrome
- C/T: typical
Members: Your genotype for rs527590 is —.
Genes associated with autoimmune reactions have links to Raynaud’s phenomenon, perhaps through the severity of the autoimmune disease.
IL1B gene: encodes the interleukin 1beta inflammatory cytokine
Check your genetic data for rs1143634 (23andMe v4, v5; AncestryDNA):
- G/G: (most common genotype) higher risk of antisynthetase syndrome (autoimmune disorder w/Raynaud’s)[ref]
- A/G: higher risk of antisynthetase syndrome (autoimmune disorder w/Raynaud’s)
- A/A: lower risk of antisynthetase syndrome (good)
Members: Your genotype for rs1143634 is —.
INFG: Interferon-gamma gene, important in the initial response to viral infections.
Check your genetic data for rs2069718 (AncestryDNA):
- G/G: increased risk of Raynaud’s in connective tissue disorder patients[ref]
- A/G: typical risk
- A/A: typical risk
Members: Your genotype for rs2069718 is —.
TNF gene: encodes the TNF-alpha inflammatory cytokine
Check your genetic data for rs1800630 (23andMe v4, v5; AncestryDNA):
- A/A: increased risk of Raynaud’s in lupus patients[ref]
- A/C: increased risk of Raynaud’s in lupus patients[ref]
- C/C: typical
Members: Your genotype for rs1800630 is —.
HTR1B gene: encodes a serotonin receptor
Check your genetic data for rs6297 (23andMe v4; AncestryDNA):
- C/C: increased risk of Raynaud’s due to hand/arm vibrations[ref]
- C/T: increased risk of Raynaud’s due to hand/arm vibrations
- T/T: typical
Members: Your genotype for rs6297 is —.
Treatments for Raynaud’s
Keep your fingers warm in the cold weather :-)
This advice was given for Raynaud’s in 1908 and is still valid today. Wear gloves, and take finger heaters with you. They even make little rechargeable heaters that you can put in your pockets in cold weather.
Talk with your doctor about medication options for Raynaud’s phenomenon. If you aren’t already diagnosed with an autoimmune disease, ask whether this could be an indicator of an underlying autoimmune condition.
Stop smoking. Smoking promotes vasoconstriction and may make Raynaud’s worse.
Natural Supplements for Raynaud’s:
The rest of this article is for Genetic Lifehacks members only. Consider joining today to see the rest of this article.
An active subscription is required to access this content.
Join Here for full access to this article, genotype reports, and much more!
Already a member? Log in below.
Related Articles and Topics:
Curcumin Supplements: Decreasing Inflammation
Have you heard that curcumin supplements offer a slew of health benefits? Discover the science behind how curcumin reduces inflammation for better outcomes in chronic diseases.CYP2A6:
Breaking down nicotine and other medications
How many cigarettes a day a person smokes – and how hard it is for them to quit – is at least partly dependent on the CYP2A6 gene. This enzyme also metabolizes several important cancer drugs.
Nitric Oxide Synthase: Heart health, blood pressure, and aging
Nitric Oxide Synthase is an important signaling molecule in the endothelium of our blood vessels. It has roles in the regulation of blood pressure, cardiovascular disease, brain health, and more. Genetic variants in nitric oxide genes are important for a healthy heart.
Research roundup: Preventing and mitigating COVID-19
Find out how your genes could play a part in the interactions with cardiovascular disease risk and blood pressure.An introduction to a series of articles on the research into things that may help to mitigate some of your risk in SARS-Cov-2 infections.
Brisset, Marion, et al. “Biallelic Mutations in Tenascin-X Cause Classical-like Ehlers-Danlos Syndrome with Slowly Progressive Muscular Weakness.” Neuromuscular Disorders: NMD, vol. 30, no. 10, Oct. 2020, pp. 833–38. PubMed, https://doi.org/10.1016/j.nmd.2020.09.002.
Chen, Qingsong, et al. “HTR1B Gene Variants Associate with the Susceptibility of Raynauds’ Phenomenon in Workers Exposed Hand-Arm Vibration.” Clinical Hemorheology and Microcirculation, vol. 63, no. 4, Oct. 2016, pp. 335–47. PubMed, https://doi.org/10.3233/CH-152021.
Curtiss, P., et al. “The Clinical Effects of L‐arginine and Asymmetric Dimethylarginine: Implications for Treatment in Secondary Raynaud’s Phenomenon.” Journal of the European Academy of Dermatology and Venereology, vol. 33, no. 3, Mar. 2019, pp. 497–503. PubMed Central, https://doi.org/10.1111/jdv.15180.
Eid, A. H., et al. “Estrogen Increases Smooth Muscle Expression of Alpha2C-Adrenoceptors and Cold-Induced Constriction of Cutaneous Arteries.” American Journal of Physiology. Heart and Circulatory Physiology, vol. 293, no. 3, Sept. 2007, pp. H1955-1961. PubMed, https://doi.org/10.1152/ajpheart.00306.2007.
Fardoun, Manal M., et al. “Raynaud’s Phenomenon: A Brief Review of the Underlying Mechanisms.” Frontiers in Pharmacology, vol. 7, Nov. 2016, p. 438. PubMed Central, https://doi.org/10.3389/fphar.2016.00438.
—. “Raynaud’s Phenomenon: A Brief Review of the Underlying Mechanisms.” Frontiers in Pharmacology, vol. 7, Nov. 2016, p. 438. PubMed Central, https://doi.org/10.3389/fphar.2016.00438.
—. “Raynaud’s Phenomenon: A Brief Review of the Underlying Mechanisms.” Frontiers in Pharmacology, vol. 7, Nov. 2016, p. 438. PubMed Central, https://doi.org/10.3389/fphar.2016.00438.
Freedman, R. R., and M. D. Mayes. “Familial Aggregation of Primary Raynaud’s Disease.” Arthritis and Rheumatism, vol. 39, no. 7, July 1996, pp. 1189–91. PubMed, https://doi.org/10.1002/art.1780390717.
Garner, Rozeena, et al. “Prevalence, Risk Factors and Associations of Primary Raynaud’s Phenomenon: Systematic Review and Meta-Analysis of Observational Studies.” BMJ Open, vol. 5, no. 3, Mar. 2015, p. e006389. PubMed Central, https://doi.org/10.1136/bmjopen-2014-006389.
Haque, Ashraful, and Michael Hughes. “Raynaud’s Phenomenon.” Clinical Medicine, vol. 20, no. 6, Nov. 2020, pp. 580–87. PubMed Central, https://doi.org/10.7861/clinmed.2020-0754.
Herrick, Ariane L. “Evidence-Based Management of Raynaud’s Phenomenon.” Therapeutic Advances in Musculoskeletal Disease, vol. 9, no. 12, Dec. 2017, pp. 317–29. PubMed Central, https://doi.org/10.1177/1759720X17740074.
—. “Evidence-Based Management of Raynaud’s Phenomenon.” Therapeutic Advances in Musculoskeletal Disease, vol. 9, no. 12, Dec. 2017, pp. 317–29. PubMed Central, https://doi.org/10.1177/1759720X17740074.
Hirankarn, N., et al. “Genetic Susceptibility to SLE Is Associated with TNF-Alpha Gene Polymorphism -863, but Not -308 and -238, in Thai Population.” International Journal of Immunogenetics, vol. 34, no. 6, Dec. 2007, pp. 425–30. PubMed, https://doi.org/10.1111/j.1744-313X.2007.00715.x.
Kaufman, Carolyn S., and Merlin G. Butler. “Mutation in TNXB Gene Causes Moderate to Severe Ehlers-Danlos Syndrome.” World Journal of Medical Genetics, vol. 6, no. 2, May 2016, pp. 17–21. PubMed, https://doi.org/10.5496/wjmg.v6.i2.17.
Khouri, Charles, et al. “Drug‐induced Raynaud’s Phenomenon: Beyond Β‐adrenoceptor Blockers.” British Journal of Clinical Pharmacology, vol. 82, no. 1, July 2016, pp. 6–16. PubMed Central, https://doi.org/10.1111/bcp.12912.
Koulouri, Vasiliki, et al. “The Role of Novel Autoantibodies in the Diagnostic Approach and Prognosis of Patients with Raynaud’s Phenomenon.” Mediterranean Journal of Rheumatology, vol. 31, no. 4, Dec. 2020, pp. 427–29. PubMed Central, https://doi.org/10.31138/mjr.31.4.427.
—. “The Role of Novel Autoantibodies in the Diagnostic Approach and Prognosis of Patients with Raynaud’s Phenomenon.” Mediterranean Journal of Rheumatology, vol. 31, no. 4, Dec. 2020, pp. 427–29. PubMed Central, https://doi.org/10.31138/mjr.31.4.427.
Lindberg, Lotte, et al. “Infrared Thermography as a Method of Verification in Raynaud’s Phenomenon.” Diagnostics, vol. 11, no. 6, May 2021, p. 981. PubMed Central, https://doi.org/10.3390/diagnostics11060981.
Munir, Sabrina, et al. “Association of Raynaud’s Phenomenon with a Polymorphism in the NOS1 Gene.” PLoS ONE, vol. 13, no. 4, Apr. 2018, p. e0196279. PubMed Central, https://doi.org/10.1371/journal.pone.0196279.
Nakamura, H., et al. “Blood Endothelin-1 and Cold-Induced Vasodilation in Patients with Primary Raynauld’s Phenomenon and Workers with Vibration-Induced White Finger.” International Angiology: A Journal of the International Union of Angiology, vol. 22, no. 3, Sept. 2003, pp. 243–49.
Nilsson, Tohr, et al. “Hand-Arm Vibration and the Risk of Vascular and Neurological Diseases—A Systematic Review and Meta-Analysis.” PLoS ONE, vol. 12, no. 7, July 2017, p. e0180795. PubMed Central, https://doi.org/10.1371/journal.pone.0180795.
Paradowska-Gorycka, Agnieszka, et al. “Interferons (IFN-A/-B/-G) Genetic Variants in Patients with Mixed Connective Tissue Disease (MCTD).” Journal of Clinical Medicine, vol. 8, no. 12, Nov. 2019, p. E2046. PubMed, https://doi.org/10.3390/jcm8122046.
Ponce-Gallegos, Marco Antonio, et al. “Genetic Susceptibility to Antisynthetase Syndrome Associated With Single-Nucleotide Variants in the IL1B Gene That Lead Variation in IL-1β Serum Levels.” Frontiers in Medicine, vol. 7, 2020, p. 547186. PubMed, https://doi.org/10.3389/fmed.2020.547186.
—. “Genetic Susceptibility to Antisynthetase Syndrome Associated With Single-Nucleotide Variants in the IL1B Gene That Lead Variation in IL-1β Serum Levels.” Frontiers in Medicine, vol. 7, 2020, p. 547186. PubMed, https://doi.org/10.3389/fmed.2020.547186.
Rosato, Edoardo, et al. “The Treatment with N-Acetylcysteine of Raynaud’s Phenomenon and Ischemic Ulcers Therapy in Sclerodermic Patients: A Prospective Observational Study of 50 Patients.” Clinical Rheumatology, vol. 28, no. 12, Dec. 2009, pp. 1379–84. PubMed, https://doi.org/10.1007/s10067-009-1251-7.
Scolnik, M., et al. “Symptoms of Raynaud’s Phenomenon (RP) in Fibromyalgia Syndrome Are Similar to Those Reported in Primary RP despite Differences in Objective Assessment of Digital Microvascular Function and Morphology.” Rheumatology International, vol. 36, no. 10, Oct. 2016, pp. 1371–77. PubMed, https://doi.org/10.1007/s00296-016-3483-6.
Shepherd, Anthony I., et al. “‘Beet’ the Cold: Beetroot Juice Supplementation Improves Peripheral Blood Flow, Endothelial Function, and Anti-Inflammatory Status in Individuals with Raynaud’s Phenomenon.” Journal of Applied Physiology, vol. 127, no. 5, Nov. 2019, pp. 1478–90. journals.physiology.org (Atypon), https://doi.org/10.1152/japplphysiol.00292.2019.
Smyth, A. E., et al. “A Case-Control Study of Candidate Vasoactive Mediator Genes in Primary Raynaud’s Phenomenon.” Rheumatology (Oxford, England), vol. 38, no. 11, Nov. 1999, pp. 1094–98. PubMed, https://doi.org/10.1093/rheumatology/38.11.1094.
Umemoto, Kanae, et al. “Acupuncture Point ‘Hegu’ (LI4) Is Close to the Vascular Branch from the Superficial Branch of the Radial Nerve.” Evidence-Based Complementary and Alternative Medicine, vol. 2019, June 2019, p. e6879076. www.hindawi.com, https://doi.org/10.1155/2019/6879076.
Urban, Nikolaus, et al. “Raynaud’s Phenomenon after COVID-19 Vaccination: Causative Association, Temporal Connection, or Mere Bystander?” Case Reports in Dermatology, vol. 13, 2021, pp. 450–56. www.karger.com, https://doi.org/10.1159/000519147.
Debbie Moon is the founder of Genetic Lifehacks. Fascinated by the connections between genes, diet, and health, her goal is to help you understand how to apply genetics to your diet and lifestyle decisions. Debbie has a BS in engineering and also an MSc in biological sciences from Clemson University. Debbie combines an engineering mindset with a biological systems approach to help you understand how genetic differences impact your optimal health.